Cargando…

Pharmacokinetics and pharmacodynamics profiles of enteric‐coated mycophenolate sodium in female patients with difficult‐to‐treat lupus nephritis

Relapsed or resistant lupus nephritis (LN) is considered a difficult‐to‐treat type of LN, and enteric‐coated mycophenolate sodium (EC‐MPS) has been used in this condition. Therapeutic drug monitoring using the area under the plasma mycophenolic acid concentration from 0 to 12 h postdose (MPA‐AUC(0–1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chariyavilaskul, Pajaree, Phaisal, Weeraya, Kittanamongkolchai, Wonngarm, Rukrung, Chutima, Anutrakulchai, Sirirat, Avihingsanon, Yingyos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283741/ https://www.ncbi.nlm.nih.gov/pubmed/35570339 http://dx.doi.org/10.1111/cts.13295

Ejemplares similares

A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience
por: Anutrakulchai, Sirirat, et al.
Publicado: (2016)

Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study
por: Suttichet, Thitima Benjachat, et al.
Publicado: (2019)

Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis
por: Puapatanakul, Pongpratch, et al.
Publicado: (2019)

SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
por: Rattanacheeworn, Punyabhorn, et al.
Publicado: (2020)

Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN)
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2019)

Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach
por: Rattanacheeworn, Punyabhorn, et al.
Publicado: (2021)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study
por: Banjongjit, Athiphat, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Mycophenolate versus Cyclophosphamide for Lupus Nephritis
por: Sahay, M., et al.
Publicado: (2018)

Comparison of Immunogenicity and Safety of Inactivated, Adenovirus-Vectored, and Heterologous Adenovirus-Vectored/mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Prospective Cohort Study
por: Assawasaksakul, Theerada, et al.
Publicado: (2022)

Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis
por: Assawasaksakul, Theerada, et al.
Publicado: (2022)

A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2013)

Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Relation of peritubular capillary features to class of lupus nephritis
por: Anutrakulchai, Sirirat, et al.
Publicado: (2016)

CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia
por: Chamnanphon, Monpat, et al.
Publicado: (2020)

Biomarkers for Refractory Lupus Nephritis: A Microarray Study of Kidney Tissue
por: Benjachat, Thitima, et al.
Publicado: (2015)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis
por: Treamtrakanpon, Worapot, et al.
Publicado: (2012)

Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
por: Kise, Tomoo, et al.
Publicado: (2015)

Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
por: Rezaieyazdi, Zahra, et al.
Publicado: (2014)

Mycophenolate or Cyclophosphamide in Lupus Nephritis: Which One to Use in Indian Patients?
por: Rathi, Manish, et al.
Publicado: (2018)

Successful Treatment of Hemophagocytic Lymphohistiocytosis Associated with Lupus Nephritis by Using Mycophenolate Mofetil
por: Nawata, Takashi, et al.
Publicado: (2017)

Effect of Combined Mycophenolate and Rapamycin Treatment on Kidney Fibrosis in Murine Lupus Nephritis
por: Zhang, Chenzhu, et al.
Publicado: (2022)

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
por: Houssiau, Frédéric A, et al.
Publicado: (2010)

The development of membranous lupus nephritis during treatment with mycophenolate mofetil for proliferative renal disease
por: Dalton, Kristen, et al.
Publicado: (2010)

Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis
por: Almutairi, Abdulaziz, et al.
Publicado: (2018)

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
por: Tamirou, Farah, et al.
Publicado: (2016)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
por: Mizaki, Tomoko, et al.
Publicado: (2023)

Development and validation of an ultra-performance liquid chromatography mass spectrometry/mass spectrometry method for simultaneous quantification of total and free mycophenolic acid and its metabolites in human plasma
por: Tanathitiphuwarat, Napatsanan, et al.
Publicado: (2020)

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
por: Moore, R Andrew, et al.
Publicado: (2006)

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
por: Mao, Youying, et al.
Publicado: (2018)

Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis
por: Zhang, Haitao, et al.
Publicado: (2020)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
por: Yap, Desmond Y.H., et al.
Publicado: (2021)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
por: Aftab, Adan, et al.
Publicado: (2022)

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study
por: Laskari, Katerina, et al.
Publicado: (2010)

Efficacy of High-Dose Mycophenolate Mofetil in Multitarget Therapy for Lupus Nephritis: Two Consecutive Case Reports
por: Furuto, Yoshitaka, et al.
Publicado: (2020)

Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing
por: Winnicki, Wolfgang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ulm9vobco3a8htibjhrss9jf6